Skip to content
Catalyst

PapersPMID:12915429

Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial.

JAMA2003The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, very limited evidenceno difference foundTotal cholesterol (TC)
  2. Finding, very limited evidenceno difference foundHDL cholesterol
Study, every finding
RCT · 8 weeks
Dose studied, every finding
standard-dose guggulipid 1000 mg or high-dose guggulipid 2000 mg, 3 times daily, for 8 weeks
Population, every finding
Healthy ambulatory community-dwelling adults with hypercholesterolemia eating a typical Western diet, Philadelphia area; standard-dose and high-dose guggulipid arms together vs placebo

No finding here moved its endpoint.

Study record

Design
randomised controlled trial
Species
human
Population
Ambulatory, community-dwelling, healthy adults with hypercholesterolemia in the Philadelphia, Pa, metropolitan area eating a typical Western diet
Participants
103
Comparator
placebo
Duration
56 days
Endpoints measured
6